Risk management of endoscopic sphincterotomy for choledocholithiasis

被引：1

作者：

Ito, Kei ^{[1
]}

Fujita, Naotaka ^{[1
]}

Noda, Yutaka ^{[1
]}

Kobayashi, Go ^{[1
]}

Horaguchi, Jun ^{[1
]}

Takasawa, Osamu ^{[1
]}

Obana, Takashi ^{[1
]}

Avd, Takuro Endo ^{[1
]}

Nakahara, Kazunari ^{[1
]}

机构：

[1] Sendai City Med Ctr, Dept Gastroenterol, Miyagino Ku, Sendai, Miyagi 9830824, Japan

来源：

DIGESTIVE ENDOSCOPY | 2007年 / 19卷

关键词：

bile duct stone; FRCP; EST; hemorrhage; pancreatitis; POST-ERCP PANCREATITIS; BILE-DUCT STONES; RANDOMIZED CONTROLLED-TRIAL; RETROGRADE CHOLANGIOPANCREATOGRAPHY; BILIARY SPHINCTEROTOMY; BALLOON DILATION; PROSPECTIVE MULTICENTER; BOLUS SOMATOSTATIN; INDUCED HEMORRHAGE; THERAPEUTIC ERCP;

D O I：

10.1111/j.1443-1661.2007.00714.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Endoscopic retrograde cholangiopancreatography (ERCP) is accepted as a safe, direct technique for evaluating pancreatobiliary diseases. Since the introduction of endoscopic sphincterotomy (EST), ERCP has evolved from a diagnostic procedure to a therapeutic one. ERCP with EST and stone removal is a valuable therapeutic modality in choledocholithiasis. Herein are reviewed the complications of EST in cases of choledocholithiasis along with a discussion of the risk management of this particular procedure. Pancreatitis is the most common FRCP-related complication. Hemorrhage is primarily a complication related to sphincterotomy. Other complications include perforation, cholangitis, cholecystitis, and sedation-related cardiopulmonary complications. Endoscopists who perform ERCP should have appropriate training and be knowledgeable of such complications.

引用

页码：S44 / S48

页数：5

共 43 条

[1] Prophylaxis of ERCP-Related Pancreatitis: A Randomized, Controlled Trial of Somatostatin and Gabexate Mesylate [J].

Andriulli, Angelo ;

Solmi, Luigi ;

Loperfido, Silvano ;

Leo, Pietro ;

Festa, Virginia ;

Belmonte, Angelo ;

Spirito, Fulvio ;

Silla, Michele ;

Forte, Giovambattista ;

Terruzzi, Vittorio ;

Marenco, Giorgio ;

Ciliberto, Enrico ;

Sabatino, Antonio ;

Monica, Fabio ;

Magnolia, Maria Rita ;

Perri, Francesco .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (08) :713-718

[2]

[Anonymous], 2002, NIH Consens State Sci Statements, V19, P1

[3] Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial [J].

Arvanitidis, D ;

Anagnostopoulos, GK ;

Giannopoulos, D ;

Pantes, A ;

Agaritsi, R ;

Margantinis, G ;

Tsiakos, S ;

Sakorafas, G ;

Kostopoulos, P .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (03) :278-282

[4]

ASGE guidelines for clinical application, 1999, GASTROINTEST ENDOSC, V50, P906, DOI DOI 10.1016/S0016-5107(99)70192-6

[5] Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: A metaanalysis of randomized, controlled trials [J].

Baron, TH ;

Harewood, GC .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (08) :1455-1460

[6] Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones [J].

Bergman, JJGHM ;

Rauws, EAJ ;

Fockens, P ;

vanBerkel, AM ;

Bossuyt, PMM ;

Tijssen, JGP ;

Tytgat, GNJ ;

Huibregtse, K .

LANCET, 1997, 349 (9059) :1124-1129

[7] Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography:: results of a randomized study [J].

Bordas, JM ;

Toledo-Pimentel, V ;

Llach, J ;

Elena, M ;

Mondelo, F ;

Ginès, A ;

Terés, J .

GASTROINTESTINAL ENDOSCOPY, 1998, 47 (03) :230-234

[8] Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography [J].

Cavallini, G ;

Tittobello, A ;

Frulloni, L ;

Masci, E ;

Mariani, A ;

DiFrancesco, V ;

Angelini, GP ;

Casarini, MB ;

Bedogni, G ;

Conigliaro, R ;

Bonardi, L ;

Khajekini, MTA ;

Cipolletta, L ;

Bianco, MA ;

Costamagna, G ;

Perri, V ;

Dobrilla, G ;

DePretis, G ;

Familiari, L ;

Giacobbe, G ;

Fratton, A ;

Carone, N ;

Loriga, P ;

Muscas, A ;

Mazzeo, F ;

Gaeta, L ;

Miglioli, M ;

Pezzilli, R ;

Morelli, A ;

Santucci, L ;

Naccarato, R ;

DelFavero, G ;

Orlandi, F ;

Macarri, GP ;

Russo, A ;

Virgilio, C ;

Uomo, G ;

Manes, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (13) :919-923

[9] Post-ERCP pancreatitis and hyperamylasemia: Patient-related and operative risk factors [J].

Christoforidis, E ;

Goulimaris, I ;

Kanellos, I ;

Tsalis, K ;

Demetriades, C ;

Betsis, D .

ENDOSCOPY, 2002, 34 (04) :286-292

[10] Analysis of 59 ERCP lawsuits; mainly about indications [J].

Cotton, PB .

GASTROINTESTINAL ENDOSCOPY, 2006, 63 (03) :378-382

← 1 2 3 4 5 →